Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Kite licences Teneobio’s multiple myeloma targeting antibodies

pharmaceutical-technologyApril 06, 2020

Tag: Kite , Teneobio , multiple myeloma

PharmaSources Customer Service